Lanthanum dioxycarbonate

碳酸二氧镧

Report date: 2025/08/13 14:48:59
NME

Base Information

Drug NameLanthanum dioxycarbonate
Drug Alias NameOxylanthanum carbonateRENALANOLC (Unicycive Therapeutics)RenaZorbSPI-014 +[7
ClassificationSmall molecules
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesAltairnano
China Registration ClassN/A

Develop Information

Active IndicationsHyperphosphatemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A